40
Participants
Start Date
July 2, 2020
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2027
Atezolizumab
Atezolizumab is a type of antibody and is administered intravenously.
Sacituzumab govitecan
Sacituzumab govitecan is an antibody drug conjugate and is administered intravenously
RECRUITING
University of Pennsylvania-Abramson Cancer Center, Philadelphia
RECRUITING
Vanderbilt-Ingram Cancer Center, Nashville
RECRUITING
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
RECRUITING
University of Chicago Medical Center for Advanced Care Orland Park, Orland Park
RECRUITING
University of Chicago Medical Center, Chicago
NOT_YET_RECRUITING
University of California San Francisco, San Francisco
RECRUITING
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Genentech, Inc.
INDUSTRY
Stand Up To Cancer
OTHER
Dana-Farber Cancer Institute
OTHER